Using RV/LV ratio and cardiac biomarkers to define the risk of mortality from pulmonary embolism.

RV/LV oranı ve kardiyak biyobelirteçlerin pulmoner emboliye bağlı mortalite riskini tanımlamada kullanımı.

Journal

Tuberkuloz ve toraks
ISSN: 0494-1373
Titre abrégé: Tuberk Toraks
Pays: Turkey
ID NLM: 0417364

Informations de publication

Date de publication:
Sep 2021
Historique:
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 30 9 2021
Statut: ppublish

Résumé

Acute pulmonary thromboembolism (PTE) is a common cause of cardiovascular mortality. Right ventricular (RV) dysfunction is the most important cause of mortality. Computed Tomography Pulmonary Angiography (CTPA) can detect right ventricular enlargement which is an indicator of RV dysfunction at the time of diagnosis. This study aimed to determine the parameters indicating RV dysfunction in CTPA and correlation of early mortality findings. In this retrospective study, electronic files of patients diagnosed PTE with CTPA between January 2012 and December 2017 were evaluated. Measurements of heart chambers, IVC reflux, and IVS morphology were calculated. In-hospital mortality of the patients after acute PTE diagnosis was evaluated. There were 206 eligible patients. Among the evaluated radiological parameters, right atrium (RA) size (p= 0.002), PA size (p= 0.003), Ao size (p= 0.006), and the presence of IVC reflux (p= 0.001) were associated with mortality. No significant relationship was found between RV/LV ≥1 and mortality (p= 0.908). All patients with PTE-related mortality had RV/LV ratio ≥1 in CTPA and had IVC reflux. Patients with an RV/LV ratio of ≥1 had statistically significantly higher troponin levels (p= 0.004) and IVC reflux (p= 0.025) compared to patients with an RV/LV ratio of <1. In conclusion, RV/LV ratio should be evaluated together with cardiac biomarkers to define mortality risk.

Identifiants

pubmed: 34581150
doi: 10.5578/tt.20219701
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

297-306

Auteurs

Sümeyye Ayöz (S)

Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Turkey.

Serhat Erol (S)

Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Turkey.

Melahat Kul (M)

Department of Radiology, Ankara University Faculty of Medicine, Ankara, Turkey.

Aslıhan Gürün Kaya (A)

Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Turkey.

Ayşegül Gürsoy Çoruh (A)

Department of Radiology, Ankara University Faculty of Medicine, Ankara, Turkey.

İsmail Savaş (İ)

Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Turkey.

Ömür Aydın (Ö)

Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Turkey.

Akın Kaya (A)

Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH